Tidelands Health

Tidelands Health
Francis B. Ford Cancer Treatment Center
2405 North Fraser Street
Georgetown, SC 29442
843-545-5600

National Cancer Institute Community Oncology Research Program logo

As an affiliate of the Medical University of South Carolina, Tidelands Health is an active Minority/Underserved NCORP site. Tidelands Health is currently active on the following clinical trials addressing various cancer types. Ask your health care provider for more information.

All Disease Sites

  • WF-30917CD: Stepped-Care Telehealth for Distress in Rural Cancer Survivors
    Trial Details

Breast

  • A011202: A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients (cT1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy
    Trial Details
  • BR003: Testing the addition of carboplatin to usual chemotherapy in high-risk triple-negative breast cancer
    Trial Details
  • EA1131: Testing platinum-based chemotherapy after surgery in triple-negative breast cancers
    Trial Details
  • EAZ171: Prospective Validation Trial of Taxane Therapy (Docetaxel or Weekly Paclitaxel) and Risk of Chemotherapy-Induced Peripheral Neuropathy in African American Women
    Trial Details
  • S1418: A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer with >/= 1 CM Residual Invasive Cancer or Positive Lymph Nodes (ypN1mi, ypN1-3) after Neoadjuvant Chemotherapy
    Trial Details
  • WF-97116: Donepezil for Cognitive Impairment (REMEMBER)
    Trial Details

Gastrointestinal

  • A021703: Randomized Double-Blind Phase III Trial of Vitamin D3 Supplementation in Patients With Previously Untreated Metastatic Colorectal Cancer (SOLARIS)
    Trial Details
  • A221805: Duloxetine to Prevent Oxaliplatin-Induced Chemotherapy-Induced Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase II to Phase III Study
    Trial Details
  • EA2165: Testing the Addition of the Drug Nivolumab after Previous Therapy for High Risk Anal Cancer
    Trial Details
  • EA2186: A Randomized Phase II Study of Gemcitabine and Nab-Paclitaxel Compared with 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan in Older Patients with Treatment Na├»ve Metastatic Pancreatic Cancer (GIANT)
    Trial Details

Head & Neck

  • HN005: Testing less intensive radiation therapy with chemotherapy or immunotherapy to treat selected low-risk patients with HPV-positive oropharyngeal cancer
    Trial Details

Thoracic/Lung

  • EA5163/S1709 INSIGNA: Testing the timing of immunotherapy alone or with chemotherapy as first line treatment and maintenance in non-small cell lung cancer
    Trial Details